@xpressandhra@KanchiMadhav Serum Institute of India, which has a manufacturing partnership for a #COVID19 vaccine by Oxford University & one by #Novavax, has announced that it will make it available at $3 or Rs 225 for low-and middle-income countries including India.
@SumiSukanya
https://t.co/QbwPdfiwFP